网站主页 >> CAS数据库列表 >> (BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯
|
|
|
- CAS号:
- 955048-92-7
- 英文名:
- FMOC-ASP(OTBU)-SER(PSI-ME,MEPRO)-OH
- 英文别名:
- Fmoc-Asp(OtBu)-Ser[Ψ(Me,Me)Pro]-OH;Fmoc-Asp(tBu)-Ser[PSI(Me,Me)Pro]-OH;FMOC-ASP(OTBU)-SER(PSI-ME,MEPRO)-OH;FMOC-ASP(OOtbu)-SER(PSI-ME,MEPRO)-OH;Fmoc-L-Asp(tBu)-L-Ser[PSI(Me,Me)Pro]-OH;FMOC-ASP(OTBU)-SER(ΨME,ME PRO)-OH-955048-92-7;Fmoc-Asp(OtBu)-Ser[Psi(Me,Me)Pro]-OH≥ 99% (HPLC);(9H-Fluoren-9-yl)MethOxy]Carbonyl Asp(OtBu)-SerPsi(Me,Me)Pro-OH;(S)-3-[Nα-(9-Fluorenylmethyloxycarbonyl)-L-aspartyl-t-butyl ester]-2,2-dimethyloxazolidine-4-carboxylic acid;(S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid
- 中文名:
- (BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯
- 中文别名:
- (BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯;(S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-4-(叔丁氧基)-4-氧代丁酰基)-2,2-二甲基恶唑烷-4-羧酸
- CBNumber:
- CB5741517
- 分子式:
- C29H34N2O8
- 分子量:
- 538.59
- MOL File:
- 955048-92-7.mol
|
|
|
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯化学性质
-
沸点:
-
753.0±60.0 °C(Predicted)
-
|
-
密度:
-
1.266±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at +2°C to +8°C.
-
|
-
酸度系数(pKa):
-
3.01±0.40(Predicted)
-
|
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯性质、用途与生产工艺
Fmoc-Asp(OtBu)-Ser(psi(Me,Me)pro)-OH 是一种二肽。
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯
上下游产品信息
上游原料
下游产品
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯
生产厂家
955048-92-7, (BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯 相关搜索:
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2-二甲基-4-恶唑烷羧酸 (5R)-3-[(2S,3S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸 (5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸 (4S)-3-[(2S,3S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代戊基]-2,2-二甲基-4-恶唑烷羧酸 FMOC-GLY-THR(PSIME,MEPRO)-OH (4S,5R)-3-(N-芴甲氧羰基丙氨酰)-2,2,5-三甲基恶唑烷-4-羧酸 (4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 (4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2-二甲基-4-恶唑烷羧酸 (5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2,5-三甲基-4-恶唑烷羧酸 (4S)-3-[2-[[芴甲氧羰基]氨基]乙酰基]-2,2-二甲基-4-恶唑烷羧酸 (BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2,5-三甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯 (4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,5-二氧代-5-[(三苯基甲基)氨基]戊基]-2,2,5-三甲基-4-恶唑烷羧酸 (GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯
- peptide
- 伪二肽
- 假二肽
- 特殊氨基酸
- (S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-4-(叔丁氧基)-4-氧代丁酰基)-2,2-二甲基恶唑烷-4-羧酸
- (BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯
- 955048-92-7
- FMOC-ASP(OOtbu)-SER(PSI-ME,MEPRO)-OH
- (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid
- 3-Oxazolidinebutanoic acid, 4-carboxy-β-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,2-dimethyl-γ-oxo-, 3-(1,1-dimethylethyl) ester, (βS,4S)-
- FMOC-ASP(OTBU)-SER(ΨME,ME PRO)-OH-955048-92-7
- (4S)-3-[(2S)-4-(tert-butoxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-oxobutanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
- (9H-Fluoren-9-yl)MethOxy]Carbonyl Asp(OtBu)-SerPsi(Me,Me)Pro-OH
- (S)-3-[Nα-(9-Fluorenylmethyloxycarbonyl)-L-aspartyl-t-butyl ester]-2,2-dimethyloxazolidine-4-carboxylic acid
- Fmoc-Asp(OtBu)-Ser[Psi(Me,Me)Pro]-OH≥ 99% (HPLC)
- Fmoc-Asp(OtBu)-Ser[Ψ(Me,Me)Pro]-OH
- Fmoc-Asp(tBu)-Ser[PSI(Me,Me)Pro]-OH
- (betaS,4S)-4-Carboxy-beta-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,2-dimethyl-gamma-oxo-3-oxazolidinebutanoic acid 3-(1,1-dimethylethyl) ester
- Fmoc-L-Asp(tBu)-L-Ser[PSI(Me,Me)Pro]-OH
- FMOC-ASP(OTBU)-SER(PSI-ME,MEPRO)-OH